ACRS vs HSY · rev $3.6M vs P/E 36, rev $5.89B
Aclaris Therapeutics Inc (ACRS) versus Hershey Co (HSY) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Hershey Co (HSY) is a confectioners company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported HSY revenue for 2026-06-28 was $5.89B. Net income was $892.8M. Revenue was up 89.8% from 2026-03-29 to 2026-06-28. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
ACRS currently screens at market cap $615.9M. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
Not investment advice. Open the ACRS and HSY stock pages for the full models.
Not investment advice.